MD Anderson at ASCO
As the oncology world focuses its attention on the American Society of Clinical Oncology Annual Meeting, MD Anderson’s experts are sharing their pioneering research and its translational application to the clinic. From cutting-edge immunotherapies and targeted therapies to advanced surgical and radiation techniques that more precisely attack tumors while preserving quality of life, our experts are leading the way to end cancer.
Learn about research findings our experts are presenting virtually at the 2021 ASCO Annual Meeting below. Bookmark this page for updates about next year’s meeting and beyond.
Featured Articles
Newly approved targeted therapy sotorasib prolongs survival in KRAS G12C-mutated lung cancer
Phase II study presented by MD Anderson at ASCO shows KRAS inhibitor is safe, offers durable clinical benefit
Progress in Ewing’s sarcoma treatment
Historically, Ewing’s sarcomas has been challenging to treat for patients with relapsed or metastatic disease. Ravin Ratan, M.D., discusses new research advances that may provide more treatment options for patients with Ewing’s sarcoma.
Combination
therapy achieves high rates of response for patients with acute
lymphoblastic leukemia
Chemotherapy-free regimen results in 100% complete response rate, 85% complete molecular remission rate in newly diagnosed patients
Meet Our Experts
Join our experts on Twitter Spaces for a discussion of the latest advances in lymphoma, myeloma, MDS and leukemia treatments from the ASCO and EHA meetings.
MD Anderson News
Moon Shots Program
MD Anderson’s Moon Shots Program® aims to rapidly and dramatically improve cancer survival rates and reduce suffering through early detection, research and new treatments.
Learn more